D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Designer Brands
DBI
$325M
| $1.03M | ﹤0.01% |
432,213
-62,152
| -13% | -$188K |
|
3102
Cognizant
CTSH
$24B
| $1.03M | ﹤0.01% |
13,165
-285,397
| -96% | -$21.9M |
|
3103
CALL
PennyMac Financial
PFSI
$4.45B
| $1.03M | ﹤0.01% |
10,300
-7,800
| -43% | -$756K |
|
3104
CALL
Monolithic Power Systems
MPWR
$63.6B
| $1.02M | ﹤0.01% |
1,400
| – | – |
|
3105
CEMIG Preferred Shares
CIG
$6.21B
| $1.02M | ﹤0.01% |
521,076
-224,666
| -30% | -$411K |
|
3106
LeMaitre Vascular
LMAT
$2.34B
| $1.02M | ﹤0.01% |
12,297
-42,716
| -78% | -$3.57M |
|
|
RAAQ
3107
DELISTED
Real Asset Acquisition Corp
RAAQ
| $1.02M | ﹤0.01% |
+100,000
| New | +$1.02M |
|
3108
PUT
Qorvo
QRVO
$7.99B
| $1.01M | ﹤0.01% |
11,900
-5,300
| -31% | -$383K |
|
|
FSP
3109
Franklin Street Properties
FSP
$50M
| $1.01M | ﹤0.01% |
615,113
-100,803
| -14% | -$168K |
|
|
WTGUU
3110
Wintergreen Acquisition Corp Unit
WTGUU
$57.7M
| $1.01M | ﹤0.01% |
+100,000
| New | +$1M |
|
3111
Orthofix Medical
OFIX
$499M
| $1.01M | ﹤0.01% |
90,333
+37,953
| +72% | +$470K |
|
3112
CALL
Alamos Gold
AGI
$12.1B
| $1.01M | ﹤0.01% |
37,900
-140,300
| -79% | -$3.75M |
|
3113
PUT
Insmed
INSM
$22.7B
| $1.01M | ﹤0.01% |
10,000
| – | – |
|
3114
Sable Offshore Corp
SOC
$796M
| $1.01M | ﹤0.01% |
45,758
+30,888
| +208% | +$719K |
|
|
ORLA
3115
CALL
Orla Mining
ORLA
$3.43B
| $1.01M | ﹤0.01% |
100,000
| – | – |
|
3116
Las Vegas Sands
LVS
$31.9B
| $1M | ﹤0.01% |
+23,086
| New | +$898K |
|
3117
Willdan Group
WLDN
$1.06B
| $1M | ﹤0.01% |
16,046
-9,151
| -36% | -$436K |
|
3118
ARS Pharmaceuticals
SPRY
$565M
| $1M | ﹤0.01% |
57,449
+23,652
| +70% | +$341K |
|
|
GCMGW
3119
DELISTED
GCM Grosvenor Inc Warrant
GCMGW
| $1M | ﹤0.01% |
1,562,787
| – | – |
|
3120
CALL
Applied Industrial Technologies
AIT
$12.8B
| $1,000K | ﹤0.01% |
4,300
-3,700
| -46% | -$842K |
|
3121
CALL
Academy Sports + Outdoors
ASO
$3.14B
| $999K | ﹤0.01% |
+22,300
| New | +$924K |
|
3122
United States Lime & Minerals
USLM
$3.38B
| $998K | ﹤0.01% |
10,002
-16,701
| -63% | -$1.63M |
|
3123
PUT
Rio Tinto
RIO
$149B
| $997K | ﹤0.01% |
17,100
+7,100
| +71% | +$419K |
|
|
AFCG
3124
AFC Gamma
AFCG
$59.5M
| $996K | ﹤0.01% |
222,399
-11,310
| -5% | -$58.2K |
|
3125
CALL
DoubleVerify
DV
$1.74B
| $991K | ﹤0.01% |
66,200
| – | – |
|
Similar funds
D.E. Shaw & Co's Q2 2025 Portfolio in Review
As of Q2 2025, D.E. Shaw & Co held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- D.E. Shaw & Co's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- D.E. Shaw & Co added most to Apple in Q2 2025, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- D.E. Shaw & Co fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- D.E. Shaw & Co opened 647 new positions and closed 532 in Q2 2025.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.